摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(+)-n-hexadecyl methyl sulfoxide

中文名称
——
中文别名
——
英文名称
(+)-n-hexadecyl methyl sulfoxide
英文别名
Sulfoxide, hexadecyl methyl;1-methylsulfinylhexadecane
(+)-n-hexadecyl methyl sulfoxide化学式
CAS
——
化学式
C17H36OS
mdl
——
分子量
288.538
InChiKey
SIBDBILRJTZBAT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.1
  • 重原子数:
    19
  • 可旋转键数:
    15
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    36.3
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    1-hexadecylmagnesium bromide(R)-1-bromo-4-(methylsulfinyl)benzene四氢呋喃 为溶剂, 反应 1.5h, 以77%的产率得到(+)-n-hexadecyl methyl sulfoxide
    参考文献:
    名称:
    亚磺酰基衍生物与格氏试剂反应中取代的苯阴离子作为离去基团:一条新的便捷途径制备高对映体纯度的二烷基亚砜
    摘要:
    DOI:
    10.1021/jo991912q
点击查看最新优质反应信息

文献信息

  • Mulls containing chain structure clay suspension aids
    申请人:THE PROCTER & GAMBLE COMPANY
    公开号:EP0034387A2
    公开(公告)日:1981-08-26
    A liquid mull is provided having improved physical stability, consisting of a liquid phase, comprising a major proportion of a nonionic surfactant and optionally a minor proportion of a nonaqueous solvent, and a dispersed solid phase comprising a particulate material which is insoluble in the liquid phase of the mull. From 1 % to 15% by weight of the composition of a chain structure type clay is included to aid the physical stability of the mull, so that insoluble particulate materials such as builders having ordinary particle sizes may also be incorporated. Preferred compositions are substantially anhydrous to allowthe optional inclusion of water sensi. tive detergency adjuvants such as enzymes or bleaches. The compositions may optionally contain up to 25% of a further dispersion aid selected from anionic surfactants, cationic surfactants, zwitterionic surfactants and hydrotropic materials. Such mulls have utility, for example, as detergent compositions.
    本发明提供了一种具有更好物理稳定性的液体闷闷不乐剂,它由液相和分散固相组成,液相主要由非离子表面活性剂和少量非水溶剂组成,分散固相由不溶于闷闷不乐剂液相的颗粒材料组成。按重量计,在组合物中加入 1%至 15%的链状结构粘土,以提高泥浆的物理稳定性,这样也可以加入不溶于泥浆的颗粒材料,如具有普通粒度的建筑材料。优选的组合物基本上是无水的,这样就可以选择性地加入对水敏感的去污佐剂,如酶或漂白剂。组合物还可以选择性地含有高达 25% 的其它分散助剂,这些助剂选自阴离子表面活性剂、阳离子表面活性剂、齐聚亚铵盐表面活性剂和亲水材料。例如,这种混合物可用作洗涤剂组合物。
  • Detergent composition containing semi-polar nonionic detergent, alkaline earth metal anionic detergent, and amidoalkylbetaine detergent
    申请人:THE PROCTER & GAMBLE COMPANY
    公开号:EP0157443A1
    公开(公告)日:1985-10-09
    A detergent composition containing a semi-polar nonionic detergent, an alkaline earth metal salt of an anionic detergent, and an amidoalkylbetaine. The composition is especially useful for the removal of greasy soils and has good suds mileage.
    一种洗涤剂组合物,含有一种半极性非离子洗涤剂、一种阴离子洗涤剂的碱土金属盐和一种氨基烷基甜菜碱。 该组合物特别适用于去除油腻污垢,并具有良好的起泡能力。
  • Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer
    申请人:LTS LOHMANN Therapie-Systeme AG
    公开号:US11033512B2
    公开(公告)日:2021-06-15
    The present invention relates to transdermal therapeutic systems (TTS) for the transdermal administration of asenapine comprising an asenapine-containing layer structure, said asenapine-containing layer structure comprising A) a backing layer and B) an asenapine-containing layer, wherein the transdermal therapeutic system comprises a silicone acrylic hybrid polymer.
    本发明涉及用于透皮给药阿塞纳平的透皮治疗系统(TTS),该系统包括含阿塞纳平层结构,所述含阿塞纳平层结构包括 A) 背衬层和 B) 含阿塞纳平层,其中透皮治疗系统包括硅丙烯酸杂化聚合物。
  • Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
    申请人:LTS LOHMANN Therapie-Systeme AG
    公开号:US11337932B2
    公开(公告)日:2022-05-24
    The present invention relates to a transdermal therapeutic system (TTS) for the transdermal administration of asenapine comprising a self-adhesive layer structure comprising a therapeutically effective amount of asenapine, said self-adhesive layer structure comprising: A) a backing layer; B) an asenapine-containing layer comprising: 1. asenapine in the form of the free base; and 2. a polymer selected from the group consisting of polysiloxanes and polyisobutylenes in an amount of more than 50% by weight based on the total weight of the asenapine-containing layer; and C) optionally an additional skin contact layer.
    本发明涉及一种用于透皮给药阿塞那平的透皮治疗系统(TTS),该系统包括一个包含治疗有效量阿塞那平的自粘层结构,所述自粘层结构包括:A) 背衬层; B) 含有阿塞那平的层,包括: 1:1. 以游离碱形式存在的阿塞那平;和 2. 选自聚硅氧烷和聚异丁烯组成的组中的聚合物,其含量超过含阿塞那平层总重量的 50%(按重量计);和 C) 可选的附加皮肤接触层。
  • Transdermal therapeutic system for the transdermal administration of rivastigmine
    申请人:LTS LOHMANN THERAPIE-SYSTEME AG
    公开号:US11389421B2
    公开(公告)日:2022-07-19
    The present invention relates to a transdermal therapeutic system (TTS) for the transdermal administration of rivastigmine comprising a rivastigmine-containing layer structure, said rivastigmine-containing layer structure comprising: A) a backing layer; and B) a rivastigmine-containing layer.
    本发明涉及一种用于透皮给药利伐斯的明的透皮治疗系统(TTS),该系统由含利伐斯的明的层结构组成,所述含利伐斯的明的层结构包括: A)背衬层;和 B)含利伐斯替mine层。
查看更多